Northwest Healthcare Properties Real Estate Investment Trust

Section1: Company Overview and Fundamental Insights:

Northwest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

Kalkine’s Real Estate Report covers the Investment Highlights, Key Financial Metrics, Risks, Technical Analysis along with the Valuation, Target Price, and Recommendation on the stock.

The top 10 shareholders together form ~18.68% of the total shareholding. Kolter Capital NWH L.L.C and BlackRock Institutional Trust Company hold a maximum stake in the company at ~10.88% and ~3.05%, respectively.

The company reported rising financials in Q2 2025, where it clocked healthy growth under its Management Fees and Share of Profit of Equity Accounted Investments, which is a key positive. Furthermore, it witnessed improving Cash and Cash Equivalents and Net Income, highlighting its strengthening profitability and operational momentum.

Section 2: Business Update and Financial Highlights

The picture below gives an overview of the company’s recent activities, such as an announcement regarding October 2025 Distribution Declared.

Section 3: Key Risks

Section 4: Stock Recommendation Summary

The stock has witnessed an upside of ~0.80% and ~3.72% over the last 1 week and 6 months respectively. Moreover, it is trading above the average 52-week high price of CAD 5.46 and 52-week low price of CAD 4.33, providing an opportunity to ride the trend.

Valuation Methodology: EV to Sales Multiple Based Relative Valuation (Illustrative):

Markets are trading in a highly volatile zone currently due to certain macroeconomic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is October 20, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Dividend Yield may vary as per the stock price movement. 

Note 5: Kalkine reports are prepared based on the stock prices captured either from REFINITIV or Trading View. Typically, REFINITIV or Trading View may reflect stock prices with a delay which could be a lag of 25-30 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.